Acute Mountain Sickness
- 29 September 1988
- journal article
- review article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 319 (13) , 841-845
- https://doi.org/10.1056/nejm198809293191306
Abstract
THE majority of persons who ascend rapidly to terrestrial elevations higher than approximately 2500 m (8200 ft) undergo an unpleasant period of acclimatization. During this time, they have a variety of symptoms, the most prominent of which are headache, nausea, vomiting, and insomnia, that are collectively referred to as acute mountain sickness.1 2 3 This paper reviews current concepts of the pathogenesis and treatment of this disorder. Factors that influence susceptibility to this condition will be discussed. Acute mountain sickness is part of a continuum of diseases related to ascension to high altitudes4 that includes the infrequent life-threatening conditions high-altitude pulmonary edema . . .Keywords
This publication has 28 references indexed in Scilit:
- Successful treatment of acute mountain sickness with dexamethasone.BMJ, 1987
- High Altitude Cerebral EdemaNeurosurgery, 1986
- Increased capillary fragility at high altitude.BMJ, 1986
- Prevention of Acute Mountain Sickness by DexamethasoneNew England Journal of Medicine, 1984
- Fluid Retention and Relative Hypoventilation in Acute Mountain SicknessRespiration, 1982
- Acute mountain sickness and the edemas of high altitude: A common pathogenesis?Respiration Physiology, 1981
- Effect of Acetazolamide on Hypoxemia during Sleep at High AltitudeNew England Journal of Medicine, 1979
- Rales, peripheral edema, retinal hemorrhage and acute mountain sicknessThe American Journal of Medicine, 1979
- THE INCIDENCE, IMPORTANCE, AND PROPHYLAXIS OF ACUTE MOUNTAIN SICKNESSThe Lancet, 1976
- Cerebrovascular response to acute hypocapnic and eucapnic hypoxia in normal manJournal of Clinical Investigation, 1970